A hemorrhagic stroke occurs when a weakened blood vessel in the brain ruptures and bleeds into the surrounding area. This type of stroke is less common than an ischemic stroke, but is also more deadly. It accounts for about 15 percent of all stroke-related deaths. The most common cause of a hemorrhagic stroke is high blood pressure, or hypertension. Other conditions, such as an aneurysm, arteriovenous malformation (AVM), or head trauma can also lead to one. Hemorrhagic strokes can present differently than ischemic strokes, so diagnosis can be difficult. Symptoms can include headache, nausea, dizziness, slurred speech, loss of feeling in the face or extremities, loss of coordination, confusion, and an inability to comprehend or respond to instructions. CT scans and MRI imaging can help to diagnose the presence of a hemorrhagic stroke, but a lumbar puncture may be needed to pinpoint the exact cause. Treatment for a hemorrhagic stroke focuses on controlling the bleeding, restoring efficient blood flow, and minimizing damage to the surrounding tissue. Different medical procedures, such as endovascular coiling, can be used to repair weakened blood vessels and stop the bleeding. Medications may be given to prevent blood clots and lower blood pressure. In some cases, lifestyle changes are recommended to lower the risk of a hemorrhagic stroke. These include maintaining healthy blood pressure levels, quitting smoking, engaging in regular exercise, limiting alcohol intake, and eating a healthy diet. Additionally, medications may be recommended to further reduce the risk of stroke. It is important for people to understand the symptoms and risk factors of a hemorrhagic stroke, so that they can seek medical help promptly and begin treatment quickly if one occurs. Early diagnosis and treatment can lead to the best possible results.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States